ATE431823T1 - Zubereitungen und verwendung eines ah-rezeptor- liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4- carbonsäure-methylester - Google Patents

Zubereitungen und verwendung eines ah-rezeptor- liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4- carbonsäure-methylester

Info

Publication number
ATE431823T1
ATE431823T1 AT02717416T AT02717416T ATE431823T1 AT E431823 T1 ATE431823 T1 AT E431823T1 AT 02717416 T AT02717416 T AT 02717416T AT 02717416 T AT02717416 T AT 02717416T AT E431823 T1 ATE431823 T1 AT E431823T1
Authority
AT
Austria
Prior art keywords
thiazole
indole
carbonyl
preparations
carboxylic acid
Prior art date
Application number
AT02717416T
Other languages
English (en)
Inventor
Hector Deluca
Jiasheng Song
Margaret Clagett-Dame
Richard Peterson
William Westler
Raphal Sicinski
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE431823T1 publication Critical patent/ATE431823T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02717416T 2001-02-14 2002-02-12 Zubereitungen und verwendung eines ah-rezeptor- liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4- carbonsäure-methylester ATE431823T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26880901P 2001-02-14 2001-02-14
PCT/US2002/004137 WO2002064138A1 (en) 2001-02-14 2002-02-12 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester

Publications (1)

Publication Number Publication Date
ATE431823T1 true ATE431823T1 (de) 2009-06-15

Family

ID=23024571

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02717416T ATE431823T1 (de) 2001-02-14 2002-02-12 Zubereitungen und verwendung eines ah-rezeptor- liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4- carbonsäure-methylester

Country Status (13)

Country Link
US (1) US6916834B2 (de)
EP (1) EP1365760B1 (de)
JP (1) JP4509478B2 (de)
AT (1) ATE431823T1 (de)
AU (1) AU2002248422B2 (de)
BR (1) BR0207689A (de)
CA (1) CA2437579C (de)
DE (1) DE60232403D1 (de)
ES (1) ES2327615T3 (de)
IL (2) IL157301A0 (de)
MX (1) MXPA03007245A (de)
NZ (1) NZ527430A (de)
WO (1) WO2002064138A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1642910A (zh) * 2002-02-12 2005-07-20 威斯康星校友研究基金会 用于ah受体作为配体的吲哚噻唑化合物的合成
JP2007516155A (ja) * 2003-10-14 2007-06-21 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ エストロゲン活性を有する（３ｒ，４ｒ）−トランス−３，４−ジアリールクロマン誘導体
EP1842541A1 (de) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Pflanzenextrakte, pflanzliche Wirkstoffe und ihre Verwendung
EP2082736A1 (de) 2008-01-23 2009-07-29 Jean Hilaire Saurat Pharmazeutische Zusammensetzung zur lokalen Anwendung
ES2791684T3 (es) * 2009-11-02 2020-11-05 Ariagen Inc ITE para la intervención y erradicación del cáncer
US10632106B2 (en) 2009-11-02 2020-04-28 Ariagen, Inc. Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
CN102775399A (zh) * 2011-12-27 2012-11-14 盛世泰科生物医药技术(苏州)有限公司 arylhydrocarbon受体(AHR)的内源性配体,2-(1’H3’-吲哚羰基)噻唑-4-羧酸甲酯的合成新方法
KR102282187B1 (ko) 2014-09-12 2021-07-26 아리아젠, 인크. 2-(1'h-인돌-3'-카르보닐)-티아졸-4-카르복실산 메틸 에스테르 및 그의 구조 유사체의 효율적이고 확장 가능한 합성
CN113480530A (zh) * 2016-12-26 2021-10-08 阿里根公司 芳香烃受体调节剂
WO2019099977A2 (en) * 2017-11-20 2019-05-23 Ariagen, Inc. Indole compounds and their use
US20210347794A1 (en) 2018-09-21 2021-11-11 Ariagen, Inc. Phosphate Derivatives of Indole Compounds and Their Use
TW202038943A (zh) * 2018-11-19 2020-11-01 美商雅里俊公司 治療癌症之方法
TW202104218A (zh) 2019-04-15 2021-02-01 美商雅里俊公司 對掌性吲哚化合物及其用途
US11136318B2 (en) 2019-06-21 2021-10-05 Noramco, Llc Processes for the preparation of aryl hydrocarbon receptor ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285931A (en) * 1964-12-21 1966-11-15 Union Carbide Corp Preparation of substituted pyrrole derivatives
GB9215361D0 (en) * 1992-07-20 1992-09-02 Wellcome Found Heterocyclic compounds
US5336685A (en) * 1993-04-12 1994-08-09 Sloan-Kettering Institute For Cancer Research Use of flavonoids to treat multidrug resistant cancer cells
US6323228B1 (en) * 2000-09-15 2001-11-27 Abbott Laboratories 3-substituted indole angiogenesis inhibitors
CN1642910A (zh) * 2002-02-12 2005-07-20 威斯康星校友研究基金会 用于ah受体作为配体的吲哚噻唑化合物的合成

Also Published As

Publication number Publication date
NZ527430A (en) 2005-03-24
IL157301A (en) 2012-03-29
JP2004527482A (ja) 2004-09-09
JP4509478B2 (ja) 2010-07-21
US20020183524A1 (en) 2002-12-05
AU2002248422B2 (en) 2006-07-06
WO2002064138A1 (en) 2002-08-22
MXPA03007245A (es) 2004-06-30
EP1365760B1 (de) 2009-05-20
EP1365760A1 (de) 2003-12-03
IL157301A0 (en) 2004-02-19
BR0207689A (pt) 2004-03-09
DE60232403D1 (de) 2009-07-02
CA2437579C (en) 2012-05-01
ES2327615T3 (es) 2009-11-02
EP1365760A4 (de) 2004-07-14
CA2437579A1 (en) 2002-08-22
US6916834B2 (en) 2005-07-12

Similar Documents

Publication Publication Date Title
DE60232403D1 (de) Zubereitungen und verwendung eines ah-rezeptor-liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4-carbonsäure-methylester
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
EP1585504A4 (de) Proteinstabilisierte liposomale formulierungen pharmazeutischer wirkstoffe
TR199901674T2 (de)
DE60220441D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
DE60215919D1 (de) 4-fluoro-n-indan-2-yl benzamid und seine verwendung als arzneimittel
BR0312500B1 (pt) Uso cosmético de derivados de merocianina e preparação cosmética
DE69912313D1 (de) Colchinolderivate als gefässschädigende mittel
ATE497385T1 (de) Neue phenylalanin-derivate
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
PT1240165E (pt) Inibidores n-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamida de quinases dependentes da ciclina
EP1180031A4 (de) Noscapinderivate als adjuvans zusammenstellungen und verwendungsmethoden davon
FR2770124B1 (fr) Instrumentation chirurgicale pour la retraction et l'ecartement de tissus mous et de vaisseaux en vue d'une approche du rachis par voie anterieure
CY1109409T1 (el) Κρυσταλλοι παραγωγου υδροξυνορεφεδρινης
EP1390741A4 (de) Auf strukturen beruhende konstruktion einer bibliothek menschlicher antikörper
CY1106255T1 (el) ΔΙΦΑΙΝΥΛΜΕΘΥΛ-ΘΕΙΑΖΟΛΙΔΙΝΟΔΙΟΝΕΣ ΚΑΙ ΑΝΑΛΟΓΑ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΕΝEPΓΟΠΟΙΗΤΩΝ PPAR-γ
NO20002686L (no) Forbedring av Peyronies sykdom
ATE183393T1 (de) Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethy )-anilid und n-(4- trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
DK1216692T3 (da) Anvendelse af alpha-CECH i kosmetiske præparater
ITRM20020016A0 (it) Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
ITMI992693A0 (it) Derivati di 2-(1h-indol-3il)-2-oxo-acetammidi ad attivita' antitumoral e
ITMI20010733A0 (it) Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
ITMI20001697A0 (it) Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita' antitumorale
ATE243684T1 (de) Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika
NO20053956L (no) Brystkreftresistentsprotein (BCRP)-inhibitor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties